Periodic Reporting for period 3 - MMpredict (Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients)

The Horizon 2020 MMpredict initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx, the Department of Haematology of the Erasmus University Medical Centre Rotterdam, the Department of Onco-Haematology of the University of Turin...